BioSurvey

BioSurvey is an online survey service specialized in the field of Life Science.

Life Science Consulting

We provide a business consulting and marketing support service which is most appropriate for the Japanese bio-marketplace.

We provide coordination and integration service for all marketing communication resources.

Biomarket.jp is a membership portal site for life science professionals (researchers) in Japan.

Study Reveals Gophers’ Biofluorescence
Mutated Tumor Suppressor Genes Interfere with Adaptive Immune System Attack on Tumor Cells; New Results Reveal “Fascinating and Unexpected Relationship Between Tumor Suppressor Genes and the Immune System,” Says HHMI Investigator Bert Vogelstein in Comment on Harvard/HHMI-Led Study Published in Science
Takeda’s EXKIVITY™ (Mobocertinib) Approved by U.S. FDA As First Oral Therapy Specifically Designed for Patients with EGFR Exon20 Insertion-Positive Non-Small Cell Lung Cancer (NSCLC); Next-Generation Sequencing (NGS) Companion Diagnostic from Thermo Fisher Scientific Approved Simultaneously
FDA Approves Tissue-Based Next-Generation Sequencing (NGS) Companion Diagnostic (CDx) for Takeda’s Targeted Therapy (EXKIVITY) for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Exon20 Insertion Mutations; Thermo Fisher Scientific’s Oncomine Dx Target Test Now Approved As CDx for Five Targeted NSCLC Therapies in U.S.

No posts.

Search for:

3F, Sanno Park Tower, 2-11-1 Nagata-cho,
Chiyoda-ku, Tokyo, Japan 100-6162
[T] +813.6205.3311

PAGE TOP